advertisement

---

Hohberger B 14

Showing records 1 to 14 | Display all abstracts from Hohberger B

96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Hohberger B
Frontiers in neuroscience 2021; 15: 676579

---

96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Hohberger B; Harrer T
Frontiers in medicine 2021; 8: 754667

---

96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Schlötzer-Schrehard U
Frontiers in neuroscience 2021; 15: 676579

---

96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Mardin C
Frontiers in medicine 2021; 8: 754667

---

96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Mardin C
Frontiers in neuroscience 2021; 15: 676579

---

96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Kruse F
Frontiers in medicine 2021; 8: 754667

---

96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Lämmer R
Frontiers in neuroscience 2021; 15: 676579

---

96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Hoffmanns J
Frontiers in medicine 2021; 8: 754667

---

96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Munoz L
Frontiers in neuroscience 2021; 15: 676579

---

96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Rogge L
Frontiers in medicine 2021; 8: 754667

---

96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Kunze R; Herrmann M
Frontiers in neuroscience 2021; 15: 676579

---

96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Heltmann F
Frontiers in medicine 2021; 8: 754667

---

96142 Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
Wallukat G
Frontiers in neuroscience 2021; 15: 676579

---

96361 Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Moritz M; Szewczykowski C; Schottenhamml J; Kräter M; Bergua A; Zenkel M; Gießl A; Schlötzer-Schrehardt U; Lämmer R; Herrmann M; Haberland A; Göttel P; Müller J; Wallukat G
Frontiers in medicine 2021; 8: 754667

---